Georgia
Fee-For-Service Medicaid Coverage of Screening
Covered
Highlighted Disparity
Asian or Pacific Islander individuals in Georgia are least likely to be diagnosed early.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases is 58.2 and significantly higher than the national rate of 54.6.
- Georgia ranks 29th among all states, placing it in the average tier.
- Over the last five years, the rate of new cases improved by 18%.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) in Georgia is 23.8%, which is significantly lower than the national rate of 26.6%.
- It ranks 32nd among the 42 states with survival data, placing it in the below average tier.
- Over the last five years, the survival rate in Georgia improved by 23%.
Early Diagnosis:
- 24.8% of cases are caught at an early stage, which is significantly lower than the national rate of 26.6%.
- It ranks 38th among the 47 states with data on diagnosis at an early stage, placing it in the below average tier.
- Over the last five years, the early diagnosis rate in Georgia improved by 17%.
Lung Cancer Treatment
Surgical Treatment:
- Georgia ranked 32nd (out of the 47 states with available data) with 18.4% of cases undergoing surgery as part of the first course of treatment.
- This is significantly lower than the national rate of 20.8% and puts Georgia in the below average tier.
- Over the last five years, the percent of cases undergoing surgery in Georgia did not change significantly.
Lack of Treatment:
- Georgia ranked 35th (out of the 47 states with available data) with 22.1% of cases not receiving any treatment.
- This is significantly higher than the national rate of 20.6% and puts Georgia in the average tier.
- Over the last five years, the percent of cases receiving no treatment in Georgia improved by 11%
Screening
Screening for High Risk:
- In Georgia, 3.8% of those at high risk were screened, which was significantly lower than the national rate of 4.5%.
- It ranks 32nd among all states, placing it in the average tier.
- Actual screening rates may be higher in states with large, regional managed care providers that did not share screening data.
Medicaid Coverage:
- Georgia was one of the 49 states whose Medicaid fee-for-service programs covered lung cancer screening as of October 2023.
- While their program used recommended guidelines for determining eligibility and did not require copays, it did require prior authorization.
Prevention
Tobacco Use:
- The smoking rate in Georgia is 15.0% and not significantly different than the national rate of 13.5%.
- It ranks 32nd among all states, placing it in the average tier.
Radon:
- In Georgia, 21.5% of radon tests results were at or above the action level recommended by EPA.
- It ranks 23rd among all states, placing it in the average tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 52.4 per 100,000 population among Black individuals in Georgia, significantly lower than the rate of 56.3 among Black individuals nationally, and significantly lower than the rate of 63.2 among white individuals in Georgia.
- The five-year survival rate is 21.3% among Black individuals in Georgia, significantly lower than the rate of 23.8% among Black individuals nationally, and significantly lower than the rate of 24.4% among white individuals in Georgia.
- 21.4% of lung cancer cases are diagnosed at an early stage among Black individuals in Georgia, significantly lower than the rate of 23.2% among Black individuals nationally, and significantly lower than the rate of 26.1% among white individuals in Georgia.
- 16.1% of Black individuals with lung cancer in Georgia underwent surgery, significantly lower than the rate of 17.0% among Black individuals nationally, and significantly lower than the rate of 19.0% among white individuals in Georgia.
- 23.6% of Black individuals with lung cancer in Georgia did not receive any treatment, significantly higher than the rate of 22.4% among Black individuals nationally, and significantly higher than the rate of 21.7% among white individuals in Georgia.
Latino individuals:
- The rate of new lung cancer cases is 35.0 per 100,000 population among Latino individuals in Georgia, significantly higher than the rate of 28.2 among Latino individuals nationally, and significantly lower than the rate of 63.2 among white individuals in Georgia.
- State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
- 22.9% of lung cancer cases are diagnosed at an early stage among Latino individuals in Georgia, not significantly different than the rate of 23.1% among Latino individuals nationally, and not significantly different than the rate of 26.1% among white individuals in Georgia.
- 22.0% of Latino individuals with lung cancer in Georgia underwent surgery, not significantly different than the rate of 21.6% among Latino individuals nationally, and not significantly different than the rate of 19.0% among white individuals in Georgia.
- 17.3% of Latino individuals with lung cancer in Georgia did not receive any treatment, significantly lower than the rate of 26.1% among Latino individuals nationally, and significantly lower than the rate of 21.7% among white individuals in Georgia.
Asian Americans or Pacific Islanders:
- The rate of new lung cancer cases is 27.3 per 100,000 population among Asian or Pacific Islanders individuals in Georgia, significantly lower than the rate of 32.9 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 63.2 among white individuals in Georgia.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- 18.0% of lung cancer cases are diagnosed at an early stage among Asian or Pacific Islander individuals in Georgia, significantly lower than the rate of 22.8% among Asian or Pacific Islander individuals nationally, and significantly lower than the rate of 26.1% among white individuals in Georgia.
- 19.2% of Asian or Pacific Islander individuals with lung cancer in Georgia underwent surgery, significantly lower than the rate of 24.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 19.0% among white individuals in Georgia.
- 19.6% of Asian or Pacific Islander individuals with lung cancer in Georgia did not receive any treatment, not significantly different than the rate of 20.2% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 21.7% among white individuals in Georgia.
Indigenous Peoples:
- The rate of new lung cancer cases is 20.2 per 100,000 population among Indigenous Peoples (American Indians/Alaska Natives) in Georgia, significantly lower than the rate of 39.4 among Indigenous Peoples nationally, and significantly lower than the rate of 63.2 among white individuals in Georgia.
- State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
- Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in Georgia due to too few cases over the time period to allow for accurate analysis.
Summary
The early diagnosis rate in Georgia falls into the below average tier. The state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
The Lung Association encourages all states to cover lung cancer screening based on the latest guidelines across all fee-for-service and managed care plans without any financial or administrative barriers in their Medicaid programs.
Georgia falls into the average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.